Pivotal phase III trial of asimadoline in patients with diarrhoea-predominant irritable bowel syndrome.
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Apr 2010
At a glance
- Drugs Asimadoline (Primary)
- Indications Irritable bowel syndrome
- Focus Registrational; Therapeutic Use
- 05 Apr 2010 Status changed from planning to not yet recruiting, as reported by Tioga Pharmaceuticals.
- 18 Feb 2010 According to a Tioga Pharmaceuticals media release, this trial along with another trial (see trial profile 700053728) are required US FDA approval.
- 22 May 2008 New trial record.